SCHEMBL13080233

SCHEMBL13080233

CC[C@H](O)C(=O)C1CCN(c2nc(-c3ccccc3O)nc3cc(C)ccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMAD3 P84022 1/20 0.48
CHEK2 O96017 3/20 0.48
TSHR P16473 5/20 0.46
MAPT P10636 4/20 0.46
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 3/20 0.44
TP53 P04637 1/20 0.44
TDP1 Q9NUW8 1/20 0.41
HIF1A Q16665 1/20 0.41
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CG P48736 1/20 0.39
HSD17B10 Q99714 2/20 0.39
CASP7 P55210 2/20 0.39
GAA P10253 1/20 0.39
CASP1 P29466 1/20 0.39
CYP1A2 P05177 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1622579 0.89 MEN1 (0.45) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL6109608 0.89 MEN1 (0.45) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL1624224 0.89 MEN1 (0.45) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL12721005 0.87 MEN1 (0.51) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL1623468 0.87 MEN1 (0.51) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL1623464 0.87 MEN1 (0.51) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL1084462 0.87 TSHR (0.58) MEN1KMT2ASMAD3CHEK2TSHR
Hydrochloric Acid SCHEMBL1623838 0.86 MEN1 (0.50) MEN1KMT2ASMAD3CHEK2TSHR
Hydrochloric Acid SCHEMBL1623836 0.86 MEN1 (0.50) MEN1KMT2ASMAD3CHEK2TSHR
SCHEMBL1084876 0.86 CHEK2 (0.49) MEN1KMT2ASMAD3CHEK2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283354-B2 Voltage gated sodium and calcium channel inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-09 US disclosed
US-8283354-B2 Voltage gated sodium and calcium channel inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-09 US disclosed